MW-150 dihydrochloride dihydrate Catalog No.:M18675-C LY3200882 specifically targets and binds

LY3200882 specifically targets and binds to TGFb

CCR2 antagonist PF-04136309 specifically binds to CCR2 and prevents binding of the endothelium-derived chemokine ligand CLL2 (monocyte chemoattractant protein-1 or MCP1) to its receptor CCR2

3-benzoxazol-6-yl)-7H-pyrrolo[2

10-Tetramethoxy-5

MW-150 dihydrochloride dihydrate Catalog No.:M18675-C LY3200882 specifically targets and bindsMW 150 dihydrochloride dihydrate (MW01 18 150SRM dihydrochloride dihydrate) is a selective, CNS penetrant, and orally active inhibitor of p38 MAPK with a Ki of 101 nM. MW 150 dihydrochloride dihydrate (MW01 18 150SRM dihydrochloride dihydrate) inhibits the ability of the endogenous p38 MAPK to phosphorylate an endogenous substrate MK2 in activated glia. Product information CAS Number: 1661020 92 3 Molecular Weight: 490. 43 Formula: C24H29Cl2N5O2